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The Flavonoid Luteolin Increases the Resistance of
Normal, but Not Malignant Keratinocytes, Against
UVB-Induced Apoptosis
Lien Verschooten1, Katrien Smaers1, Sofie Van Kelst1, Charlotte Proby2, Daniel Maes3, Lieve Declercq4,
Patrizia Agostinis5 and Marjan Garmyn1
Adequate protection of skin against the carcinogenic effects of UVB irradiation is essential. Flavonoids may have
a conspicuous role in cancer prevention because of their antioxidant, anti-inflammatory, and growth-inhibitory
effects. Therefore, we tested the effects of the flavone luteolin (LUT) on selected parameters of the sunburn
response in normal human keratinocytes, exposed to physiological doses of UVB. LUT attenuated UVB-induced
cell death through delay and inhibition of intrinsic apoptotic signaling. Moreover, LUT not only predominantly
affected the mitochondrial apoptosis pathway through its antioxidant capacity, but also changed the balance
of Bcl2 (B-cell leukemia/lymphoma 2)-family members. Furthermore, LUT had inhibitory effects on the
UVB-induced release of the inflammatory mediators, IL-1a and prostaglandin-E2. Using different cell lines
derived from squamous cell carcinomas, we showed that LUT did not increase the resistance of malignant
keratinocytes to UVB. Our data suggest that LUT inhibits different aspects of the sunburn response, which
results ultimately in an increased survival of normal keratinocytes, whereas the sensitivity of malignant cells
to UVB remain unchanged. Hence, LUT might have value in new photoprotective applications or improve
existing ones.
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INTRODUCTION
Flavonoids, part of the group of the polyphenols, are
exclusively produced in plants through the phenylpropanoid
pathway to help plants to cope with stress; for instance, UV
irradiation and oxidative stress (Harborne and Williams,
2000; Julsing et al., 2006). These natural compounds show
strong antioxidant effects and some also show other
biochemical effects in human cells, such as enzyme
inhibition, anti-inflammatory, and anticarcinogenic capaci-
ties (Nijveldt et al., 2001). These characteristics make
flavonoids potent candidates for photoprotective applications
(Morquio et al., 2005; Afaq and Mukhtar, 2006; Verschooten
et al., 2006a).
Luteolin (LUT or 30,40,5,7-tetrahydroxyflavone), which is
structurally categorized under the flavones, is known as a
very good antioxidant (Cai et al., 1997). This can be ascribed
to its highly hydroxylated structure, which contains the
known structural antioxidant features of flavonoids (Rice-
Evans et al., 1996). Furthermore, LUT has been shown to
have anti-inflammatory effects (Gutierrez-Venegas et al.,
2006) and even anticancer activity through interference with
several signaling pathways, such as mitogen-activated protein
kinase, NF-kB, PI3K/AKT (phosphatidylinositol-3-kinase/
acutely transforming retrovirus AKT8 in rodent T cell
lymphoma) (Lin et al., 2008), and the specific induction of
apoptosis (Ramos, 2007). The topical application of Achyro-
cline satureioides and perilla leaf extract, both containing a
significant amount of LUT, inhibited UV-induced reactive
oxygen species (ROS) formation in rabbits (Morquio et al.,
2005) and 12-O-tetradecanoylphorbol-3-acetate (TPA)-in-
duced tumor formation in mice (Ueda et al., 2003),
respectively. A very recent study, in which a LUT-rich
Reseda extract was applied to human skin before UVB
irradiation, showed the potential of LUT in the prevention of
UVB-induced erythema (Casetti et al., 2009).
Our skin, as the biggest organ covering our body, is
equipped with several structural and biochemical features to
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protect our inner body against several environmental stresses.
The exposure of the skin to solar UV on earth (containing
UVB and UVA radiation) has both short-term and long-term
deleterious wavelength-dependent effects on skin. In contrast
to tanning and sunburn, which occur shortly after UVB
exposure, long term UVB effects include photoaging and
photocarcinogenesis. Although UVB is still considered the
most important risk factor for squamous cell carcinoma (SCC)
of the skin, the contribution of the more abundant UVA
component of sunlight is gaining more and more support
(Mouret et al., 2006). UVB is thousand times more effective
than UVA in inducing a sunburn response (de Gruijl, 2002),
which is in fact an acute inflammatory response of the skin,
visible as erythema. At the microscopic level, it is character-
ized by an inflammatory infiltrate, vasodilatation, formation
of sunburn cells, and depletion of Langerhans cells. Several
proinflammatory cytokines (e.g., IL-1a) secreted by keratino-
cytes or other immune competent cells, as well as vasoactive
mediators (e.g., prostaglandin E2 (PGE2)), are important
mediators of the sunburn response (Rhodes et al., 2009).
UVB irradiation damages skin cells through direct and
indirect mechanisms. Direct absorption of UVB by DNA
results in the formation of pyrimidine dimers. However, other
aromatic chromophores also undergo structural changes after
UVB photon absorption. This can result in the formation of
aggressive radicals and ROS, which in turn can damage
proteins, lipids, and DNA as an indirect consequence of UVB
irradiation (Jin et al., 2007).
Upon perseverance of the cellular damage, UVB elicits a
fail-safe mechanism evidenced by the formation of sunburn
cells, representing keratinocytes undergoing apoptosis to
ensure the disposal of the damaged, cancer-prone cells
(Claerhout et al., 2006). Sunburn cells are morphologically
characterized by cell shrinkage, formation of pyknotic nuclei
with condensed chromatin, and finally membrane blebbing
and the formation of apoptotic bodies. In their final stage,
they are engulfed by surrounding phagocytotic cells, mini-
mizing a possible inflammatory response (Van Laethem et al.,
2005). The formation of sunburn cells is regulated through
several signaling cascades arising from DNA damage,
membrane receptor clustering, and ROS formation, conver-
ging into the permeabilization of the outer mitochondria
membrane, and ultimately resulting in the activation of
caspases and apoptotic cell death (Zimmermann et al., 2001).
Apoptosis functions in healthy epidermis in a well-balanced
way to remove irreversibly damaged cells without killing
healthy proliferating cells, which may abrogate the barrier
function of the epidermis. However, in malignant cells
apoptosis is often deregulated, allowing clonal expansion of
damaged cells. In the protection of skin against the harmful
effects of UVB, one has to be careful not to stimulate the
survival of damaged cells, nor to protect cells with a
deranged genetic background.
Although LUT is known as an excellent antioxidant
(Lopez-Lazaro, 2009), and it reduces UVB-induced erythema
in human skin (Casetti et al., 2009), the effects of LUT on the
molecular aspects of the sunburn response in human skin
cells have not been investigated yet. In this study, we
investigated the effect of LUT on apoptosis and other selected
parameters of the sunburn response in normal human
keratinocytes (NHKs) as well as in malignant keratinocytes
exposed to a physiological UVB dose. We found that LUT
was very efficient in inhibiting the sunburn response in NHK,
as it interfered with the intrinsic apoptosis pathway and
with the release of proinflammatory mediators after
UVB irradiation. On the contrary, LUT did not affect UVB-
induced apoptosis in malignant keratinocytes, thus showing
a high degree of specificity in its sunburn protection
mechanism of action.
RESULTS
LUT increases cell survival in NHKs after UVB irradiation
NHKs were treated 24 hours before and immediately after
apoptotic doses of UVB irradiation with LUT. This low,
nontoxic dose of LUT significantly increased the resistance to
UVB irradiation, as shown by a higher retention of metabolic
activity (Figure 1a) and by significantly higher cell viability
(Figure 1b) until 72 hours after irradiation. Light microscopic
pictures, shown in Figure 1c, illustrate the decreased
sensitivity of LUT-treated cells to a UVB dose that is lethal
to the control cells. Note a slight change in the morphology of
LUT-treated NHKs (Figure 1c). In the presence of LUT, NHKs
appear to grow slower and more in clusters in comparison to
untreated or vehicle-treated cells. We could confirm the
growth-inhibitory effect by plotting the proliferation curve
of long-time exposure of NHK to LUT (Supplementary
Figure S1a online). Both morphological changes and growth
inhibition suggest the induction of differentiation. Indeed,
LUT-treated cells showed an increase of involucrin, a late
differentiation marker, at the protein level (Supplementary
Figure S1b online).
LUT delays the apoptotic response of human keratinocytes
UVB irradiation induced an apoptotic phenotype in NHKs
within 16 hours, including caspase 3 activation and subse-
quent cleavage of poly(adenosine diphosphate-ribose) poly-
merase (PARP) (Figure 2a). Treatment with LUT before and
immediately after irradiation with UVB inhibited and delayed
UVB-induced cleavage of caspase 3 and PARP (Figure 2a).
Nevertheless, a fraction of LUT-treated cells did finally
undergo apoptosis at 48 hours after irradiation, which
indicates that the apoptotic machinery is not completely
suppressed by LUT. These data are further confirmed and
quantified by flow cytometric analysis of propidium iodide-
stained NHKs (Figure 2b), showing that LUT delays DNA
fragmentation and thus decreases the fraction of ‘‘SubG1’’
cells at all tested time points after irradiation as also shown by
the visualization of pyknotic nuclei by Hoechst 33342
staining (Figure 2c and d).
As direct DNA damage is one of the triggers leading to
apoptosis, we checked the effect of LUT on the induction and
repair of cyclobutane pyrimidine dimers (CPDs) after a low
and high UVB dose. In cells irradiated with nonlethal UVB
doses, a part (27.5%) of the CPDs were removed within
24 hours. Exactly the same pattern of induction and repair
was observed in the LUT-treated cells (Figure 2e), indicating
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that the repair capacity is preserved but that LUT does not
induce further repair nor reduces initial DNA damage. In
cells exposed to a high UVB dose (240 mJ cm–2) resulting in
apoptosis, no repair was observed in both untreated and
LUT-treated cells (Supplementary Figure S2 online). These
data indicate that the effect of LUT on apoptosis is mediated
through interference with indirect damage.
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Figure 1. Luteolin (LUT) increases the survival of normal human
keratinocytes (NHKs) after UVB irradiation. (a) MTT assay of NHKs grown in
the presence or absence of LUT (10 mM) 24 hours after irradiation with 120 or
240 mJ cm–2 of UVB. The graph represents relative values of metabolic activity
by normalization to unirradiated controls (at least 8 wells/conditions, graph of
three experiments; **Po0.001). (b) The viability of NHKs treated or not with
LUT was obtained using Trypan blue analysis on three successive days after
UVB irradiation (120 mJ cm–2) (experiment performed twice in duplicate).
(c) Morphologic pictures of NHKs, grown in the presence of vehicle alone or
LUT, 24 hours after sham or UVB irradiation (scale bar ¼ 100mm; arrows
point to death cells).
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Figure 2. Luteolin (LUT) inhibits and delays UVB-induced apoptosis. (a)
Western blot analysis of normal human keratinocytes (NHKs) treated with LUT
or DMSO and/or UVB (120 mJ cm–2) at different time points after irradiation.
(b) Flow cytometry analysis of propidium iodide (PI)-stained NHKs at indicated
time points (representative of three independent experiments, n¼ 3, Po0.05).
(c) NHK, DMSO- or LUT-treated, irradiated or not (120 mJ cm–2), were stained
with Hoechst33342 and visualized. Pyknotic cell percentage was calculated by
counting at least 10 fields of each condition mentioned (Po0.001).
(d) Representative pictures of Hoechst33342-stained cells 24 hours after UVB
irradiation (scale bar ¼50mm; arrows point to cell with condensed nuclei).
(e) Immunodetection of cyclobutane pyrimidine dimers (CPDs) in genomic
DNA of cells irradiated or not with 30 mJ cm–2 UVB and harvested immediately
or 24 hours after irradiation (representative experiment, Po0.05).
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LUT influences apoptosis, at least partially, through modulating
the mitochondrial apoptotic pathway
In concordance with the antioxidant properties of LUT
(Cai et al., 1997), UVB-induced ROS, as measured by the
shift in 20,70-dichlorofluorescin diacetate (DCFDA) fluores-
cence, were reduced in LUT-treated cells (Figure 3a). As
ROS-mediated pathways in UVB-treated NHKs are crucially
involved in mitochondrial apoptosis, we evaluated the effect
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Figure 3. Luteolin (LUT) inhibits UVB-induced mitochondrial effects. (a) DCFDA-H2 stained normal human keratinocytes (NHKs), treated or not with LUT,
were analyzed using a flow cytometer. Reactive oxygen species (ROS) was measured 16 hours after irradiation as the increase in fluorescence intensity
(representative experiment, n¼3). (b) Percentage of cells with changed mitochondrial membrane potential (Dcm) was measured by staining NHK cells
with DiOC6 followed by flow cytometric analysis (n¼ 3, representative experiment). (c) Fluorescence microscopy using Mitotracker Red and anti-cytochrome
c antibody 16 hours after treatment (scale bar ¼ 20 mm; arrows indicate cells with cytochrome c release). (c’) Quantification of western blot analysis (using
UnScanIt) of cytosolic lysates of NHKs 16 hours after irradiation. (d) The fold increase in activity of caspase 9, 16 hours after UVB irradiation. (e) Western blot
analysis of lysates of LUT- and/or UVB-treated cells (quantification using UnScanIt).
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of LUT on reduction of the mitochondrial membrane
potential (Dcm) and mitochondrial outer membrane
permeabilization. Figure 3b clearly shows that the reduction
of Dcm after UVB was inhibited by LUT until 24 hours
after UVB, and, to a lesser extent, until 48 hours after
irradiation. These results are consistent with our observations
showing inhibition but not a complete block of apoptosis
(Figure 2).
Upon mitochondrial outer membrane permeabilization,
cytochrome c is released from the mitochondria into the
cytosol, and triggers the activation of caspase 9 through the
formation of the apoptosome (Kroemer et al., 2007).
Immunofluorescent staining of NHKs (Figure 3c) and western
blot analysis (Figure 3c’) showed that LUT inhibited the
release of cytochrome c 16 hours after UVB irradiation (as
colocalization between cytochrome c and the mitochondria
was observed in nearly all LUT-treated cells (Figure 3c)), and
the subsequent activation of caspase 9 (Figure 3d) was
inhibited.
Because mitochondrial outer membrane permeabilization
is primarily regulated by Bcl2 (B-cell leukemia/lymphoma 2)-
family members, we next evaluated whether LUT affected the
intracellular ratio between antiapoptotic (i.e., Bcl2) and
proapoptotic (i.e., Bax) family members at the protein
level. NHKs treated with LUT, for at least 24 hours, showed
higher levels of Bcl2, whereas the level of active Bax
(detected using BaxNT antibody) was not influenced (Figure
3e). As expected, UVB irradiation of control NHKs resulted in
an increased pool of active Bax, whereas Bcl2 levels slightly
decreased. Addition of LUT partially prevented UVB-
mediated Bax activation and concomitantly maintained
Bcl2 levels higher, thus resulting in a higher Bcl2/active
Bax ratio in agreement with the protective effects on Dcm and
on cytochrome c release.
LUT diminishes the release of important inflammatory
mediators upon UVB irradiation
UVB irradiation of skin in vivo is followed by the known
sunburn reaction, which is mediated by the release and
action of proinflammatory cytokines, vasoactive mediators,
and adhesion molecules. The inducible form of the
cyclooxygenase enzyme (COX), COX-2, is known to
be the major enzyme responsible for the UVB-induced
prostaglandin synthesis, predominantly of PGE2. Although
we could not detect an inhibitory effect of LUT on the COX-2
protein level after UVB (Supplementary Figure S3a online),
LUT was able to inhibit the release of PGE2 upon UVB
irradiation (Figure 4a). In control conditions, we detected
increasing amounts of PGE2 in the supernatant from
3 hours after-irradiation. In LUT-treated keratinocytes, the
initially lower PGE2 release did not increase significantly
until at least 24 hours after UVB treatment with 120 mJ cm–2
(Figure 4a). We also measured the release of IL-1a
because it is an important cytokine in the UVB response
of NHKs. Similarly, we could detect an inhibitory effect of
LUT on the release of this cytokine in response to UVB
irradiation (120 mJ cm–2) until at least 24 hours after UVB
(Figure 4b).
LUT does not influence the survival of UVB-exposed skin
cancer cells
Unlike the stimulatory effect of LUT on apoptosis observed in
different cancer cell lines (Lopez-Lazaro, 2009), the above
results indicate an inhibitory effect on apoptosis in normal,
human keratinocytes irradiated with UVB. However, UV
protection of premalignant or malignant skin cells by LUT
should be avoided, as these cells might give rise to skin
cancer. Therefore, we tested whether LUT influences the
survival of skin cancer cells after UVB exposure. We used
MET1 cells, derived from a primary cutaneous SCC (Proby
et al., 2000), and exposed them to LUT and to apoptotic
doses of UVB as we did with the NHKs. The morphological
analysis (Figure 5a) showed a similar fraction of detached and
death cells in vehicle- and LUT-treated cells.
In addition, using Trypan blue viability assay (Figure 5b)
and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) (Figure 5c), we, respectively, found a
comparable amount of viable cells and of metabolic activity
in DMSO and LUT condition. To exclude a protective effect
of LUT on UVB-induced apoptosis in cancer cells, we
analyzed the fraction of subG1 cells and indeed found no
reduction of apoptotic cell death in the LUT-treated samples
(Figure 5d). To rule out a cell-specific effect, we examined
the cleavage of caspase 3 and PARP as markers of apoptotic
signaling after UVB and/or LUT treatment in different
SCC cell lines, namely, MET1-, MET4- (Proby et al., 2000),
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A431-, and A253-SCC cells. Figure 5e shows that LUT did not
inhibit UVB-induced apoptosis in all SCC-derived cells.
To exclude the effect of the medium used for SCC cell
lines, we repeated a subset of experiments in NHKs grown in
the same medium as the SCC cells. The western blot for
apoptotic markers shown in Supplementary Figure S4
online confirmed that the protective effect of LUT against
UVB-induced cell death in NHKs was independent of the
medium used.
All together, these results indicate that although LUT did
protect NHKs significantly against UVB-mediated sunburn
responses, it did not increase the resistance of malignant cells
to UVB.
DISCUSSION
In this study, we show that LUT increases the survival of NHK
upon UVB irradiation through inhibition/suppression of the
mitochondrial intrinsic apoptotic pathway. However, LUT
does not inhibit UVB-induced apoptosis in malignant
keratinocytes. LUT also reduces UVB-induced release of
PGE2 and IL1-a in keratinocytes, indicating a protection
against the UVB-induced sunburn response.
Previous work indicated that ROS-mediated cascades are
required to engage the mitochondrial pathways of UVB-
induced apoptosis in NHKs (Van Laethem et al., 2006).
Although the structure of the flavonoid 3,’40,5,7,-tetrahydrox-
yflavone or LUT is extremely suitable for antioxidant effects,
these effects are concentration and cell-type dependent. We
expected LUT, as a good antioxidant, to inhibit apoptosis
mainly through inhibition of the mitochondrial pathway.
Indeed, after UVB irradiation, we could show a LUT-
dependent inhibition of different characteristics of the
mitochondrial apoptosis pathway, including ROS production,
loss of Dcm, and subsequent release of cytochrome c from the
mitochondria into the cytosol. Besides the direct ROS
scavenging effect, LUT also increased the level of Bcl2
protein in NHKs. In contrast to control cells, these high Bcl2
levels were maintained after UVB irradiation, thereby
changing the Bcl2/active Bax balance in favor of the
antiapoptotic Bcl2 member. A similar effect has been
observed in keratinocytes treated with epigallocathecin-3-
gallate (Chung et al., 2003).
The apoptotic response of normal skin cells can be
observed as a final escape mechanism to cope with damaged
DNA. Namely, unrepaired photodimers (primarily CPDs),
because of excessive UVB irradiation, lead to programmed
cell death predominantly under regulation of p53 (Verschooten
et al., 2006b). Therefore, it remains to be established whether
the prosurvival effect of LUT through suppression of UVB-
induced mitochondrial apoptosis is beneficial for the cell in
the long term. Although LUT delays the induction of cell
death, allowing the cells more time for specific repair of
photodimers through nucleotide excision repair, we could
not detect a significant reduction of CPDs because of LUT
treatment in UVB-irradiated NHKs. Thus, we cannot
provide evidence that the cells surviving UVB irradiation at
late time points are entirely damage free. Therefore, we
recommend the use of DNA-repair stimulating agents or
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Figure 5. Effect of luteolin (LUT) on the sensitivity of malignant skin cells to
UVB. (a) Light microscopic pictures of LUT- and/or UVB-treated (240 mJ cm–2)
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(representative experiment, n¼ 16). (d) Flow cytometric analysis of propidium
iodide (PI)-stained MET1 cells treated or not with LUT and UVB (240 mJ cm–2).
SubG1 cell fraction reflects the percentage of cells with defragmented DNA
(representative experiment out of 3, n¼ 3). (e) Squamous cell carcinoma
(SCC) cells were exposed to LUT and/or UVB. Cell lysates were analyzed by
western blot using specific antibodies. Actin was used as a loading control.
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enzymes in the case that LUT might be used for photo-
protective application.
However, LUT does not completely inhibit apoptotic
signaling, but rather delays cell death by apoptosis. Hence,
apoptotic cell death is still possible at later time points for
cells in which damage is beyond repair. Moreover, as LUT
also induced growth inhibition and differentiation, indicated
by the induction of the late differentiation marker, involucrin,
eventually surviving cells with damaged DNA might not be
able to give rise to tumor formation. Further investigation of
the UV-induced DNA damage in LUT-treated skin equiva-
lents or organ cultures might reveal whether differentiation
and consequently the thickening of the Stratum Corneum
decreases damage in the proliferating basal layer of the
epidermis.
Excessive exposure of skin to solar irradiation leads to a
sunburn reaction, which is mediated by proinflammatory
cytokines (e.g., IL-1a) and vasoactive mediators (e.g., PGE2),
secreted at least partially by epidermal keratinocytes (Grone,
2002). Our results, obtained with specific ELISAs for the main
proinflammatory and vasoactive mediators, namely IL-1a and
PGE2, showed a strong inhibition by LUT treatment of the
UVB-induced release in the supernatant of cultured NHKs.
The anti-inflammatory effects of LUT can be explained as an
indirect consequence of its ROS scavenging capacity.
Although the inducible COX-2 enzyme is responsible for
PGE2 synthesis upon UVB irradiation, COX-2 protein level
was not decreased in LUT-treated keratinocytes after UVB
(Supplementary Figure S3a online). This indicates that LUT is
able to block COX-2 activity (PGE2 release), whereas it does
not affect COX-2 protein level, consistent with a previous
structural–activity relationship analysis of LUT (Rosenkranz
and Thampatty, 2003). The expression of IL-1a and other
proinflammatory cytokines, chemokines, and enzymes is
primarily regulated through NF-kB and activator protein-1.
The study of the anti-inflammatory capacity of LUT after LPS
treatment in different cell types in vivo and in vitro revealed
LUT-dependent inhibition of both pathways (Gutierrez-
Venegas et al., 2006). PGE2 release specifically, and also a
proinflammatory microenvironment in general, are not only
related to the sunburn response, but are also believed to
contribute to epithelial tumor formation and progression.
Hence, anti-inflammatory drugs are of great interest in the
prevention and treatment of epithelial skin cancers (Mueller,
2006).
The differential effect of LUT on UVB response in normal
versus malignant keratinocytes suggests that the effect of LUT
on the survival of cells after UVB irradiation depends on the
malignancy of the cells themselves. Malignant cells often
contain a higher background of ROS because of their
upregulated metabolism (Ralph et al., 2010). In hepatoma
cells, e.g., the anticancer activity of LUT is mediated through
a further increase of intracellular ROS, which ultimately leads
to cell death (Yoo et al., 2009). Important pathways,
especially those related to survival and apoptosis, are
deregulated in cancer cells (Claerhout et al., 2006). The
SCC cell lines used in this study show abnormalities in the
PI3K/AKT pathway (Claerhout et al., 2010) that might
influence the effects of LUT treatment (Lin et al., 2008).
Finally, as suggested above, induction of differentiation might
increase the resistance of normal human keratinocytes to
UVB (Hsu et al., 2005). Cancer cells, by definition, lose the
capacity to differentiate, which may also partially explain the
opposite effect of LUT on normal versus malignant cells.
All together, LUT might have potential value in photo-
protective applications, as it inhibits different components of
the sunburn response, leading to selective increased survival
of NHKs, without affecting the sensitivity of malignant
keratinocytes to UVB. Further in vivo investigation is required
to confirm the photoprotective effect of LUT in human skin.
MATERIALS AND METHODS
Reagents and antibodies
Luteolin (Sigma, St Louis, MO) was dissolved in DMSO and kept
protected from light. We purchased the PARP, the Bcl2, the COX-2,
and the cytochrome c antibody from BD Biosciences (Erembode-
gem, Belgium), the involucrin antibody from Santa Cruz (Heidel-
berg, Germany), and the BaxNT antibody from Upstate
Biotechnology (Lake Placid, NY). Antibodies against the cleaved
form of caspase 3 and caspase 9 and the secondary horseradish
peroxidase-labeled goat anti-mouse and goat anti-rabbit antibodies
were obtained from Cell Signaling Technology (Beverly, MA). The
primary antibody against actin (JLA20) was purchased from
Developmental Studies Hybridoma Bank at the University of Iowa.
Alexa Fluor goat anti-rabbit 488, MitoTrackerRed CMXRos, Hoechst
33342, DiOC6, and H2DCFDA were purchased from Molecular
Probes (Eugene, OR).
Cell culture and UVB irradiation
Primary human keratinocytes were isolated from foreskins of donors
(o5 years), as previously described (Gilchrest, 1983; Claerhout et al.,
2007), pooled to circumvent interindividual differences, and grown in
specific keratinocyte serum-free medium (Gibco-Invitrogen, Merelbeke,
Belgium), supplemented with bovine pituitary extract (50mg ml–1) and
human recombinant epidermal growth factor (5 ng ml–1). The proce-
dure has been approved by the ethical committee of the University of
Leuven. MET1 and MET4 keratinocyte cell lines, respectively, derived
from a primary epidermal tumor and from metastatic SCC within left
axillary lymph nodes from the same patient (Proby et al., 2000), were
grown in DMEM plus HAMS F12 (Invitrogen) medium containing
10% fetal calf serum, hydrocortisone, mouse epidermal growth factor,
and antibiotics. A253 and A431 cells, derived from a head and neck,
and a vulvar SCC, respectively, were grown in DMEM enriched with
10% fetal calf serum and antibiotics. All cells were grown in
incubator at 37 1C in 5% CO2.
UVB irradiation has been described in previous studies (Claerhout
et al., 2007). In brief, cells were irradiated at subconfluence (70–80%)
with Philips (Anderlecht, Belgium) TL20W12 tubes through a thin
layer of phosphate-buffered saline and through the lid of the dishes.
Output was measured using an IL700 radiometer (with an SED240/
UVB-1 filter) (International light, Newburyport, MA).
Viability assays
Metabolic activity was assessed using MTT (Sigma). After 1 hour of
incubation with MTT (1 mg ml–1), the formation of the formazan
dissolved in DMSO was measured spectrophotometrically.
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In addition, cell viability was assessed using the Trypan blue
exclusion assay, analyzed using a Vi-cell XR cell viability analyzer
(Beckman Coulter, Fullerton, CA) or Countess Cell Counter (Invitrogen).
Western blot analysis
At indicated time points after treatment, cell lysates were made as
reported in previous studies (Claerhout et al., 2007). After determina-
tion of the protein concentration using the BCA Protein Assay Reagent
(Pierce Chemical Company, Rockford, IL) according to the manu-
facturer’s protocol, samples containing equal amounts of protein
(20–50mg) were prepared and processed on the NuPAGE Novex
system (4–12% Bis-Tris; Invitrogen) and transferred to Hybond-C
Super membrane (Amersham Pharmacia Biotech, Piscataway, NJ).
Protein bands were visualized using enhanced chemiluminescence as
described by the supplier (Amersham Pharmacia Biotech).
Hoechst staining
Nuclear changes were visualized by staining the cells for 10 minutes
with the Hoechst 33342 dye (3 mM in phosphate-buffered saline),
followed by examination under a fluorescence microscope.
Detection of DNA fragmentation
Cells were trypsinized, fixed in ethanol, and stained with propidium
iodide. SubG1 fraction was analyzed using FACS Calibur (BD
Biosciences) (Van Laethem et al., 2006).
Immunodetection of CPDs
Genomic DNA of trypsinized cells was purified using a genomic
DNA extraction kit (Qiagen, Crawley, UK). Polyvinylchloride 96-
well flat-bottomed multiwell plates, precoated with 0.003%
protamine sulfate, were coated with equal amounts (200 ng) of
sample DNA. Using specific anti-CPD antibody and the tetramethyl-
benzidine ELISA detection kit (Bio-Rad, Hercules, CA), CPDs were
quantitated spectrometrically.
Analysis of mitochondrial outer membrane permeabilization
and ROS production
Cells were incubated with 3,30-dihexyloxacarboxyanine iodide
(DiOC6; 30 nM) or 2
0,70-dichlorodihydrofluorescein diacetate
(H2DCFDA; 10 mM) at 37 1C for 30 minutes, harvested by trypsiniza-
tion, and kept at 4 1C. Dcm or ROS production was analyzed using
FACS Calibur (Van Laethem et al., 2006).
Analysis of cytochrome c release
The cells were prepared for the immunofluorescence analysis as
described before (Van Laethem et al., 2006), using MitoTrackerRed
CMXRos (50 nm) and secondary fluorescent Alexa 488 anti-mouse
antibody (Molecular Probes). After mounting with 4,6-diamidino-
2-phenylindole vectashield mounting medium, analysis was
performed with an Olympus (Aartselaar, Belgium) cell imaging
station. Cellular fractionation was performed using a digitonin buffer
(0.01% digitonine and phosphatase inhibitors) and verified using
anti-cytochroomoxigenase antibody. Both fractions were processed
for western blot as described above.
Measurement of caspase activity
Caspase 9 Glo assay (Promega, Madison, WI) was performed
according to the manufacturer’s protocol. Readout was performed
using a VICTOR3 Multilabel counter and Wallac software (Perkin
Elmer, Waltham, MA) 60 minutes after addition of the substrate.
Measurement of PGE2 and IL-1a release by ELISA
The concentrations of PGE2 and IL-1a in the culture medium were
measured using the IL-1a/IL-1F1 (KGE004) and PGE2 ELISA assay kit
(DY200) (R&D Systems, Abingdon, UK) according to the manufac-
turer’s instructions.
Statistical analysis
The data were expressed as means±SD. Statistical analysis was
performed using Student’s t-test (two tailed). The criterion for
statistical significance was taken as Po0.05 unless stated otherwise.
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